ArticleCurrent oncology (Toronto, Ont.)2021

Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database.

Heidi A I Grosjean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.